{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-023216","form_type":"8-K","ticker":"OSUR","cik":"0001116463","company_name":"ORASURE TECHNOLOGIES INC","filed_at":"2022-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.657733+00:00","generated_at":"2026-06-22T02:50:28.917843+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"OraSure posts record Q3 revenue of $116.5M, up 116% YoY; InteliSwab drives growth","bullets":["GAAP net income $5.3M ($0.07 diluted EPS) vs. loss of $15.0M a year ago; non-GAAP EPS $0.13.","InteliSwab COVID-19 test revenue $79.6M, up 85% sequentially; core diagnostics revenue +14% YoY.","Q3 operating cash flow $16.3M positive vs. ($19.1M) in 2021; cash balance $101.6M.","Q4 revenue guidance $95-100M (49-57% YoY growth); expects continued positive cash flow."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-023216","json":"https://secwatch.observer/filing/0000950170-22-023216.json","markdown":"https://secwatch.observer/filing/0000950170-22-023216.md","text":"https://secwatch.observer/filing/0000950170-22-023216.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1116463/000095017022023216/0000950170-22-023216-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1116463/000095017022023216/osur-20221108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T02:50:28.917843+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"adf00ff6bfba17a470c4ae1df3d9fa81b393f141","claim":"ORASURE TECHNOLOGIES INC reported the three months ended September 30, 2022 results: revenue $116.5 million, net income $5,273, EPS 0.07.","evidence_excerpt":"Communications 484-425-0588 sgleason@orasure.com Media Contact: Amy Koch Sr. Mgr. Corporate Communications 484-523-1815 media@orasure.com OraSure Reports 3Q22 Record Revenue of $116.5 Million Growing 116% Year-Over-Year InteliSwab® revenue of $79.6 million in Q3, up 85% sequentially; Company continues to expand test production capacity Company wins new contracts for","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1116463/000095017022023216/0000950170-22-023216-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended September 30, 2022"},{"label":"Revenue","value":"$116.5 million"},{"label":"Net income","value":"$5,273"},{"label":"EPS","value":"0.07"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}